Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 7INDUSTRY 3NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 2Carcinoma, Basal Cell 2Uterine Cervical Dysplasia 1Neoplasm Metastasis 1

Interventions

Nivolumab 4Biopsy 4Specimen Handling 3Ipilimumab 3CTLA-4 Antigen 3prednylidene 2deltacortene 2Prednisone 2Magnetic Resonance Spectroscopy 2Imiquimod 2Celecoxib 2talimogene laherparepvec 1endonuclease V, phage T4 1Tacrolimus 1Sirolimus 1Microarray Analysis 1Isotretinoin 1Deoxyribonuclease (Pyrimidine Dimer) 1Chemoprevention 1Biological Therapy 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Carcinoma, Basal Cell × Imiquimod × Clear all
NCT00066872 2013-09-17

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

National Cancer Institute (NCI)

Phase 3 Completed
500 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00079300 2013-04-26

Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡